pharma · Lupus Nephritis · Generalized Myasthenia Gravis · AUPH
Aurinia Pharmaceuticals
Aurora Pharmaceutical is a pharma organization headquartered in northfield, USA. It trades on NYSE under ticker AUPH. Primary therapeutic focus areas include Lupus Nephritis, Generalized Myasthenia Gravis, Dry Eye Syndro
1196 Hwy 3 South, Northfield, MN 55057, US HQ
2007 Founded
81 Employees
Public company Type
AUPH · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1196 Hwy 3 South, Northfield, MN 55057, US
- Founded
- 2007
- Employees
- 81
- Programs
- 14
- Drugs
- 10
- Patents
- 7
Voclosporin
Phase 3 · small molecule · Lupus Nephritis
Voclosporin for Lupus Nephritis is a Phase 3 program (small_molecule) at Aurinia Pharmaceuticals with 3 ClinicalTrials.gov record(s).
Internal code AUR-VCS-2016-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Aurinia Pharmaceuticals
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Lupus Nephritis
- Status
- completed
- Trials
- 3